Digital Look

Welcome to Digital Look++,
you are not logged in

Hikma Pharmaceuticals (HIK)

Pharma and Biotech

2,012.00p

	$ (Millions)	$ (Millions)	$ (Millions)	$ (Millions)	$ (Millions)
	31-Dec-22	31-Dec-21	31-Dec-20	31-Dec-19	31-Dec-18
Continuing Operations
Revenue	2,517.00	2,553.00	2,341.00	2,207.00	2,070.00

EBITDA	439.00	556.00	647.00	465.00	429.00
Depreciation & Amortisation	(40.00)	(23.00)	(137.00)	n/a	n/a

Operating Profit/(Loss)	399.00	533.00	510.00	465.00	429.00
Interest Payable	(29.00)	(30.00)	(69.00)	(67.00)	(54.00)
Interest Receivable/Investment Income	81.00	69.00	47.00	67.00	3.00

Group Profit after Interest	451.00	572.00	488.00	465.00	378.00
Share of Assoc Cos/JV Profits	n/a	1.00	n/a	n/a	n/a

Profit Before Tax	451.00	573.00	488.00	465.00	378.00
Tax	(42.00)	(124.00)	(99.83)	(4.00)	(73.00)

Profit After Tax	409.00	449.00	388.17	461.00	305.00

Discontinued Operations
Profit After Tax	n/a	n/a	n/a	n/a	n/a

PROFIT FOR PERIOD	409.00	449.00	388.17	461.00	305.00

Attributable to:
Equity Holders of Parent Company	406.00	450.00	389.17	460.00	302.00
Minority Interests	(3.00)	1.00	1.00	(1.00)	(3.00)

Equity Dividends	_cn/a	_cn/a	_cn/a	_cn/a	_cn/a
Retained Profit/(Loss) for the Financial Year	_c406.00	_c450.00	_c389.17	_c460.00	_c302.00

Per Share Record - Normalised	31-Dec-22	31-Dec-21	31-Dec-20	31-Dec-19	31-Dec-18
Continuing EPS
Earnings per Share - Basic	181.25¢	194.81¢	164.90¢	190.08¢	125.31¢
Earnings per Share - Diluted	180.44¢	193.13¢	163.52¢	189.30¢	124.79¢
Earnings per Share - Adjusted	181.00¢	194.80¢	172.90¢	150.40¢	137.80¢
Continuing and Discontinued EPS
Earnings per Share - Basic	181.25¢	1.97¢	164.90¢	190.08¢	62.66¢
Earnings per Share - Diluted	180.44¢	1.95¢	163.52¢	189.30¢	62.40¢
Earnings per Share - Adjusted	181.00¢	194.80¢	172.90¢	150.40¢	137.80¢

Dividend per Share	56.00¢	54.00¢	50.00¢	44.00¢	38.00¢

Key Financals	31-Dec-22	31-Dec-21	31-Dec-20	31-Dec-19	31-Dec-18
Shares in Issue (millions)
Shares in Issue - Year End	220.07	231.50	243.33	242.32	241.46
Weighted Average	224.00	231.00	236.00	242.00	241.00
Diluted	225.00	233.00	238.00	243.00	242.00

Performance Ratios
Continuing Operations
Operating Margin	15.85%	20.88%	21.79%	21.07%	20.72%
Return on Capital Employed	17.15%	0.22%	22.82%	23.25%	13.54%
Continuing Operations & Discontinued Operations
Return on Equity	18.85%	0.18%	17.97%	21.53%	8.88%

Financial Status
Continuing Operations
Interest Cover - Continuing	16.55	20.10	8.07	7.94	8.00
Revenue per Share	1,123.66¢	11.16¢	991.95¢	911.98¢	429.46¢
Pre-Tax Profit Per Share - Continuing	201.34¢	2.50¢	206.78¢	192.15¢	78.42¢

Market Data
Continuing Operations
Earnings Per Share Growth - Basic	-7%	18%	-13%	52%	6%
Earnings Per Share Growth - Diluted	-7%	18%	-14%	52%	6%
PE Ratio - Company Adjusted	10.8	14.3	19.2	13.2	17.2
PEG - Company Adjusted	n/a	0.8	n/a	0.3	2.9
Dividend Cover	3.24	3.61	3.30	4.32	3.30
Continuing Operations & Discontinued Operations
Earnings per Share - Company Adjusted	9,118%	-99%	-13%	203%	-52%
Earnings per Share - Diluted	9,156%	-99%	-14%	203%	-52%
PE Ratio - Company Adjusted	10.8	1,417.2	19.2	13.2	34.4
PEG - Company Adjusted	0.0	n/a	n/a	0.1	n/a
Dividend Cover	3.24	0.04	3.30	4.32	1.65

Market Capitalisation $ (Millions)	3,415.47	5,136.94	6,127.10	4,824.57	4,143.37
Dividend per Share	56.00¢	54.00¢	50.00¢	44.00¢	38.00¢
Dividend Yield	2.9%	1.9%	1.6%	1.8%	1.8%
Dividend per Share Growth	3.70%	8.00%	13.64%	15.79%	15.15%

* GAAP

a. Includes discontinued activities

b. Includes preference dividends

c. Not disclosed under IFRS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.